glp-1 receptor agonists and cardiovascular outcome trials an update The effects of beyond obesity type 2 diabetes: anti-atherosclerotic action Real-World Evidence for GLP-1 Receptor

Studies have shown that bitter-tasting pharmaceuticals and substances, including polyphenols such as isosinensetin, bind to bitter taste receptors, and unlike other TAS2R agonists, stimulate GLP-1 secretion in NCI-H716 cells [192] (Fig

Main body The influence of DPP-4 on bone metabolism occurs through two axes

Effect of once-weekly Exenatide in patients with type 2 diabetes Mellitus with and without heart failure and heart failure-related outcomes: insights from the EXSCEL Trial

The high heterogeneity of the results likely responds to different baseline A1c, variable rates of obesity, as well as different titration protocols to adjust insulin doses

2023 American society of anesthesiologists practice guidelines for preoperative fasting: carbohydrate-containing clear liquids with or without protein, chewing gum, and pediatric fasting duration-a modular update of the 2017 American society of anesthesiologists practice guidelines for preoperative fasting

"When I talk to patients about weight management, I always bring up these other options as well, because some people don't want to use a needle." Older prescription weight loss pills include: Hydrogel ( Plenity ) Naltrexone-bupropion ( Contrave ) Orlistat ( Xenical ) Phentermine (Adipex, Suprenza) Phentermine topiramate (Qsmyia) While the GLP-1 agonists can produce a weight loss of 10% to 20%, the average weight lost with older medications is lower in the range of 5% to 10% of the starting body weight